409 related articles for article (PubMed ID: 16027111)
1. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence.
Kim DH; Langlois MA; Lee KB; Riggs AD; Puymirat J; Rossi JJ
Nucleic Acids Res; 2005; 33(12):3866-74. PubMed ID: 16027111
[TBL] [Abstract][Full Text] [Related]
2. DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1.
Pettersson OJ; Aagaard L; Andrejeva D; Thomsen R; Jensen TG; Damgaard CK
Nucleic Acids Res; 2014 Jun; 42(11):7186-200. PubMed ID: 24792155
[TBL] [Abstract][Full Text] [Related]
3. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
Langlois MA; Lee NS; Rossi JJ; Puymirat J
Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
[TBL] [Abstract][Full Text] [Related]
4. Tackling the pathogenesis of RNA nuclear retention in myotonic dystrophy.
Mastroyiannopoulos NP; Shammas C; Phylactou LA
Biol Cell; 2010 Jul; 102(9):515-23. PubMed ID: 20690904
[TBL] [Abstract][Full Text] [Related]
5. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
[TBL] [Abstract][Full Text] [Related]
6. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.
Fardaei M; Larkin K; Brook JD; Hamshere MG
Nucleic Acids Res; 2001 Jul; 29(13):2766-71. PubMed ID: 11433021
[TBL] [Abstract][Full Text] [Related]
7. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing.
Paul S; Dansithong W; Kim D; Rossi J; Webster NJ; Comai L; Reddy S
EMBO J; 2006 Sep; 25(18):4271-83. PubMed ID: 16946708
[TBL] [Abstract][Full Text] [Related]
8. Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles.
Holt I; Mittal S; Furling D; Butler-Browne GS; Brook JD; Morris GE
Genes Cells; 2007 Sep; 12(9):1035-48. PubMed ID: 17825047
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
[TBL] [Abstract][Full Text] [Related]
10. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.
Mankodi A; Logigian E; Callahan L; McClain C; White R; Henderson D; Krym M; Thornton CA
Science; 2000 Sep; 289(5485):1769-73. PubMed ID: 10976074
[TBL] [Abstract][Full Text] [Related]
11. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios.
Tiscornia G; Mahadevan MS
Mol Cell; 2000 Jun; 5(6):959-67. PubMed ID: 10911990
[TBL] [Abstract][Full Text] [Related]
12. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
13. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation.
Amack JD; Mahadevan MS
Hum Mol Genet; 2001 Sep; 10(18):1879-87. PubMed ID: 11555624
[TBL] [Abstract][Full Text] [Related]
14. Trinucleotide-repeat expanded and normal DMPK transcripts contain unusually long poly(A) tails despite differential nuclear residence.
Gudde AEEG; van Kessel IDG; André LM; Wieringa B; Wansink DG
Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):740-749. PubMed ID: 28435090
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells.
Langlois MA; Boniface C; Wang G; Alluin J; Salvaterra PM; Puymirat J; Rossi JJ; Lee NS
J Biol Chem; 2005 Apr; 280(17):16949-54. PubMed ID: 15722335
[TBL] [Abstract][Full Text] [Related]
18. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
19. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
Sobczak K; Wheeler TM; Wang W; Thornton CA
Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
[TBL] [Abstract][Full Text] [Related]
20. Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.
Childs-Disney JL; Hoskins J; Rzuczek SG; Thornton CA; Disney MD
ACS Chem Biol; 2012 May; 7(5):856-62. PubMed ID: 22332923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]